Introduction
============

Pseudoexfoliative (PEX) syndrome is a generalized disorder of the extracellular matrix characterized by the production and accumulation of fibril granulated protein (exfoliative material) in the anterior eye segment tissues and connective tissue of visceral organs ([@r1]-[@r4]). PEX syndrome is a disorder associated with older age, found all over the world population, however, with great ethnic and geographical differences in its prevalence. The average age at its onset across the populations is ≥60 years, while the average prevalence is estimated to 10%-20%. In the eye, PEX syndrome manifests as the presence of pseudoexfoliative material deposits on the anterior lens capsule, ciliary body, zonules, pupillary edge, corneal endothelium, anterior vitreous, trabeculum and connective tissue in the eyeball ([@r4]-[@r7]). The etiopathogenesis of the syndrome has not yet been fully clarified, but it is known to involve both genetic and non-genetic factors. Recent research supports the pathogenetic concept of PEX syndrome as a form of stress induced systemic elastosis associated with overproduction and progressive accumulation of fibrillar material in the anterior eye segment tissues and connective tissue of visceral organs (liver, lung, heart, kidney and vascular walls). Several genes have been recognized as most responsible for development of PEX syndrome, in particular lysyl oxidase-like 1 (LOXL1) gene polymorphism on chromosome 15q24.1 in the populations investigated, with a contribution of additional genes with relatively small effects (clustrein, contactin associated protein-like 2 (CNTNAP2), apolipoprotein E, glutathione S-transferase, adenosine, and tumor necrosis factor-alpha (TNF-α)). LOXL1 polymorphism is related to the action of profibrillar transforming growth factor-beta (TGF-β) and tissue inhibitors of metalloproteinases (TIMPs) with consequential progressive production and accumulation of PEX material. Current concepts also confirm the effect of oxidative stress in the genesis of PEX syndrome, as well as impaired cellular self-defense, along with reduced levels of tissue antioxidants, leading to impaired matrix metabolism and inducing proinflammatory state ([@r8], [@r9]). Pathologic production and deposition of PEX material has been associated with development of intraocular complications (corneal endotheliopathy, iridopathy with reduced pupillary opening, ciliary body alterations, instability and degenerative changes of zonular apparatus, increased lens mobility, lens or intraocular graft decentration and dislocation, pigment dispersion, secondary open-angle and angle-closure glaucoma, pseudouveitis, anterior synechiae, and anterior chamber hypoxia). The condition poses an increased risk of intraoperative complications (lesions of zonular apparatus, rupture of lens capsule, loss of vitreous, prolonged time of postoperative inflammatory reaction, and postoperative elevation of intraocular pressure) ([@r7], [@r10]-[@r13]). PEX syndrome poses a four-fold greater risk of glaucoma ([@r14]). In the presence of PEX syndrome, glaucoma develops in 15%-20% of cases within 10 years. According to the onset mechanism, it is secondary open-angle or angle-closure glaucoma, both showing progressive course and poor therapeutic response. PEX glaucoma develops as secondary open-angle glaucoma in 15%-20% of open-angle glaucoma cases. Accumulation of PEX material and pigment in chamber angle, as well as morphological changes in the trabecular space, Schlemm's canal, juxtacanalicular space, presence of synechiae, iridal tissue atrophy, weakness of zonular apparatus, increased lens mobility and lens forward migration, and ciliary block condition increase resistance to aqueous humor circulation and drainage, and increase intraocular pressure in the eye with PEX syndrome ([@r1], [@r10]). Modern operative techniques employed in cataract surgery and refractive surgery, and use of new-generation biometric formulas to calculate intraocular lens strength require extensive and accurate preoperative biometric ophthalmologic status in order to achieve the best possible postoperative results. Previous studies using various biometric methods attempted to explain the relationships between biometric aberrations and pathophysiological events in the eye with PEX syndrome and PEX glaucoma, and their effect on the occurrence of intra- and postoperative complications. It is well known that PEX syndrome is one of the most common causes of complications in cataract surgery, whereas the results of previous studies on biometric factor aberrations in the eye with PEX syndrome with or without glaucoma are contradictory.

Aberrations in the values of biometric factors such as lower anterior chamber depth (ACD), lower pupillary diameter (PD) and higher lens thickness (LT) point to zonular apparatus instability, presence of synechiae, forward lens migration and increased mobility of the lens or intraocular artificial lens implant ([@r13], [@r15]). Preoperative detection of biometric factor aberrations enables assessment of the risk of intra- and postoperative complications in cataract and glaucoma surgery, and the need of operative technique and intraocular artificial lens implant adjustment.

The aim and purpose of the present study was to determine biometric factors of the eye specific for the group of glaucomatous patients with PEX syndrome and variation in biometric factors among the study groups of eyes by use of optical low-coherence reflectometry (OLCR), and to define the role of OLCR in the diagnosis of glaucomatous patients with PEX syndrome. OLCR is a non-contact, noninvasive biometric method providing extensive biometric status by simultaneous measurement of central corneal thickness (CCT), ACD, corneal curvature radius (K1 and K2 keratometry), PD, astigmatism (AST), white-to-white corneal diameter (WTW), axial length of the eye (AL), LT and retinal thickness (RT).

Patients and Methods
====================

The investigation was designed as a retrospective, observational study aiming to compare the results of biometric measurements performed by OLCR in different study samples. Data were collected from medical documentation on patients scheduled for cataract surgery at Department of Ophthalmology, Sveti Duh University Hospital in Zagreb, Croatia. Three groups of eyes based on the preset characteristics were established, using the inclusion/exclusion criteria: eyes with PEX syndrome and cataract; eyes with PEX glaucoma and cataract; and eyes with primary open-angle glaucoma (POAG) and cataract. Results of preoperative biometric measurements obtained by OLCR on a Lenstar LS 900® (Haag-Streit International, Köniz,Switzerland) were analyzed. The study included 102 eyes of 72 patients (44 female and 28 male) older than 40, examined before cataract surgery. There were 29 eyes with PEX syndrome and cataract; 36 eyes with POAG and cataract; and 37 eyes with PEX glaucoma and cataract.

Inclusion criteria
------------------

1.  Presence of POAG and cataract

2.  Presence of anterior eye segment lesions typical for PEX syndrome (PEX material on pupillary margin and lens capsule) along with the presence of cataract but free from lesions typical for glaucoma

3.  Presence of lesions in the anterior eye segment and chamber angle typical for PEX syndrome, with medical history and signs of glaucoma and cataract

Exclusion criteria
------------------

Patients scheduled for cataract surgery diagnosed with cataract and other pathologic or post-traumatic eye lesions during the process of preoperative biometric diagnostics, and patients diagnosed with another form of primary or secondary glaucoma in addition to cataract

Medical documentation of each patient contained the following data necessary for the study:

-   medical history (data on age, sex, presence/absence of eye disease prior to cataract surgery and on previous diseases)

-   ophthalmologic status (visual acuity, biomicroscopy results, intraocular pressure value measured by applanation tonometry, results of fundus examination by direct and indirect ophthalmoscopy, visual field changes described, and quantitative results of biometric measurements carried out by OLCR on a Lenstar LS 900® (Haag-Streit International, Köniz, Switzerland).

Lenstar LS 900® (Haag-Streit International, Köniz, Switzerland) is an optical biometer using 820 nm superluminescent diode as a source of coaxial infrared rays, has a spectrum range of 20-30 nm and short 30-µm coherence, resulting in high spatial resolution. The device provides thorough biometric status by simultaneous measurement of CCT, ACD, K1 and K2, PD, AST, WTW, AL, LT and RT. The method is non-contact, noninvasive, rapid, painless, and cannot be performed in case of nontransparent optical media (e.g., complete lens opacity, vitreous hemorrhage or retinal detachment).

Ethics
------

The use of patient medical documentation and study design were approved by Ethics Committee of Sveti Duh University Hospital, Zagreb.

Statistics
----------

In order to get answers to the questions posed in the study, we used statistical tests to compare the mean results recorded in the three groups of eyes (eyes with PEX syndrome and cataract; eyes with PEX glaucoma and cataract; and eyes with POAG and cataract) for the study parameters (AL, ACD, K1, K2, AST, LT, CCT, RT, PD and WTW). Depending on the normal or non-normal data distribution, analysis of variance (normal data distribution) or Kruskal-Wallis test (non-normal data distribution) was performed, both intended to test the level of statistical significance when comparing more than two groups. We also analyzed differences in the measured values within particular groups according to age and sex. Depending on data distribution, we used analysis of variance (normal data distribution) or Kruskal-Wallis test (non-normal data distribution). Results of these tests showed whether there were age and sex differences in the mean measured values for a particular diagnosis. The level of statistical significance was set at 5%.

Results
=======

The study included 102 eyes of 72 patients (44 female and 28 male). Female predominance was higher in the PEX syndrome/cataract group (63.6% female and 27.4% male) and POAG/cataract group (63.0% female and 27.0% male) as compared with the PEX glaucoma/cataract group (54.5% female and 36.5% male); however, this difference did not reach statistical significance (χ^2^=0.486; ss=2; p=0.784). The mean age was 79.61±6.50 and 79.41±5.27 years in the PEX syndrome/cataract and PEX glaucoma/cataract groups, respectively. In the POAG/cataract group, the mean age was younger (70.81±7.80 years). Patient age differed statistically significantly according to diagnosis (F2/69=14.204; p\<0.001). Statistically significant differences were recorded between the PEX syndrome/cataract and POAG/cataract groups and between the PEX glaucoma/cataract and POAG/cataract groups (Scheffe test, p\<0.001 both) ([Fig. 1](#f1){ref-type="fig"}). There was no age difference between patients diagnosed with PEX syndrome/cataract and those with PEX glaucoma/cataract (Scheffe test, p=0.995). Analysis of biometric status of eyes diagnosed with PEX syndrome/cataract according to age yielded significant correlation only with LT (r=0.564; p=0.008), i.e. older patients had a statistically significantly higher LT value.
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Comparison according to sex yielded a statistically significant difference in pupillometry results (t=2.474; ss=20; p=0.022), i.e. women showed higher mean PD as compared with men (M=5.7±1.103 mm *vs*. M=4.6±0.855 mm). In the POAG/cataract group, neither age nor sex difference reached statistical significance. Analysis of biometric status of the eyes diagnosed with PEX glaucoma/cataract according to age showed statistically significant correlation with LT (r=0.472; p=0.027) and WTW (r=0.512; p=0.015). Older patients had thicker lens and smaller corneal diameter. Testing according to sex yielded no statistically significant differences. Comparative analysis of biometric factors measured in all study groups (PEX syndrome/cataract, POAG/cataract and PEX glaucoma/cataract) revealed statistically significant differences in CCT (F~2/99~=7.066; p=0.001) and LT (F~2/96~=5.133; p=0.008) ([Table 1](#t1){ref-type="table"}). The eyes diagnosed with PEX syndrome/cataract had a statistically significantly greater CCT than those diagnosed with PEX glaucoma/cataract (564.6±39.54 µm *vs*. 531.4±8.95 µm; Scheffe test, p=0.002). Other CCT differences did not reach statistical significance (POAG/cataract *vs*. PEX glaucoma/cataract: Scheffe test, p=0.081; and PEX syndrome/cataract *vs*. POAG/cataract: Scheffe test, p=0.302) ([Fig. 2](#f2){ref-type="fig"}). Analysis of the results showed the eyes diagnosed with PEX syndrome/cataract and those with PEX glaucoma/cataract to have a statistically significantly thicker lens than the eyes diagnosed with POAG/cataract (4.7±0.444 mm and 4.7±0.417 mm, respectively *vs*. 4.4±0.417 mm; Scheffe test, p=0.041 and p=0.018, respectively). Lens thickness did not differ between the eyes diagnosed with PEX syndrome/cataract and those with PEX glaucoma/cataract (Scheffe test, p=0.995) ([Fig. 3](#f3){ref-type="fig"}).

###### Comparative analysis of biometric factors according to study groups

        PEX syndrome + cataract   POAG + cataract   PEX glaucoma + cataract   F; df; p                                          
  ----- ------------------------- ----------------- ------------------------- ---------- ------- -------- ---- ------- -------- ------------------------
        n                         M                 SD                        n          M       SD       n    M       SD       
  AL    27                        22.8              0.771                     35         22.9    1.092    30   23.0    0.819    0.599; 2/89; 0.703
  CCT   29                        564.6             39.547                    36         550.6   29.243   37   531.4   38.951   7.066; 2/99 0.001\*\*
  ACD   29                        2.3               0.397                     36         2.5     0.395    36   2.4     0.551    1.258; 2/98; 0.289
  LT    27                        4.7               0.444                     36         4.4     0.417    36   4.7     0.435    5.133; 2/96; 0.008\*\*
  K2    29                        43                1.299                     36         43.5    1.742    37   43.2    1.143    0.894; 2/99; 0.412
  K1    29                        43.9              1.330                     36         44.2    1.843    37   44.2    1.132    0.638; 2/99; 0.530
  AST   29                        0.9               0.465                     36         2.1     7.716    37   1.0     0.591    3.519; 2; 0.172^\#^
  WTW   29                        12.0              0.495                     36         11.9    0.634    36   11.8    0.702    1.369; 2/98; 0.259
  PD    29                        5.2               1.194                     35         5.1     1.329    32   4.6     0.927    2.732; 2/93; 0.07

PEX syndrome = pseudoexfoliative syndrome; POAG = primary open-angle glaucoma; PEX glaucoma = pseudoexfoliative glaucoma; AL = axial length; CCT = central corneal thickness; ACD = anterior chamber depth; LT = lens thickness; K1 = keratometry of the steepest meridian; K2 = keratometry of the flattest meridian; AST = astigmatism; WTW = horizontal corneal diameter (white-to-white); PD = pupillary diameter; n = number of patients; M = arithmetic mean; SD = standard deviation; F = analysis of variance; df = degrees of freedom; p = probability of error; \*\*p\<0.01; ^\#^Kruskal-Wallis test
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Discussion
==========

Assessment of biometric status of the eye has a major role in cataract, glaucoma and refractive surgery. The use of new generation biometric formulas requires thorough analysis of biometric measures in the eye in order to achieve the best possible postoperative results. Furthermore, previous studies have documented the relationship of aberrations in particular biometric factors with a higher risk of intra- and postoperative complications in cataract surgery. Knowing the biometric status of the eye in detail is a precondition for successful operative course prediction, adjustment and selection of operative techniques and intraocular artificial lens implants, and for postoperative result assessment. PEX syndrome is a disorder of the elderly, frequently associated with development of cataract and glaucoma.

Our study included 102 eyes in 72 patients (44 female and 28 male), clearly showing female predominance (60.6%), which could be explained by demographic characteristics of the population and greater proportion of women in the elderly population in general. The prevalence of PEX syndrome is known to be higher in women, whereas PEX glaucoma occurs more frequently in men ([@r5], [@r6]). In the present study, the proportion of women was greater in the PEX syndrome/cataract and POAG/cataract groups (63%) as compared with the PEX glaucoma/cataract group (55%). In the latter, the proportion of men was higher as compared with the other two groups; however, the difference was not statistically significant (χ^2^=0.486; ss=2; p=0.784).

The mean patient age was significantly higher in the PEX syndrome/cataract and PEX glaucoma/cataract groups (79.61±6.50 and 79.41±5.27 years, respectively) as compared with the POAG/cataract group (70.81±7.80 years) (Scheffe test, p\<0.001). The results obtained are consistent with literature data on the risk of PEX syndrome and PEX glaucoma to rise with age. The incidence of PEX syndrome is on an increase with population aging worldwide ([@r5], [@r6]). PEX syndrome is a generalized disorder that involves almost all segments of the eye, mostly bilaterally. It develops gradually and the lesions are considered to occur much earlier than becoming clinically visible on the lens capsule and pupillary opening. Therefore, it is of utmost importance to support development of diagnostic methods to directly or indirectly point to lesions in the earlier stage of the disease. Previous studies employing various biometric methods have reported contradictory results on biometric characteristics of the eye with PEX syndrome and PEX glaucoma.

In our sample of eyes divided into three groups, we recorded statistically significant CCT differences between the PEX syndrome/cataract and PEX glaucoma/cataract groups (564.6±39.54 µm *vs*. 531.4±38.95 µm; Scheffe test, p=0.002). The group of eyes diagnosed with PEX glaucoma and cataract had a significantly thinner cornea as compared with the other two groups. Using ultrasound (US) pachymetry and comparison of samples of normotensive and PEX syndrome eyes with and without glaucoma, Puska *et al*. report on significantly higher CCT values in patients with PEX syndrome ([@r16]). Results consistent to ours have been published by Bechmann *et al*.; using optical coherence tomography, they point to lower CCT values measured in patients with PEX glaucoma ([@r17]). In contrast, Arnarsson *et al*. (Reykjavik Eye Study) found no association between the presence of PEX syndrome and aberrations in CCT, ACD and LT values ([@r5]). Using the Pentacam Scheimpflug imaging system, Doganay *et al*. found no CCT and PD differences among patients with PEX glaucoma, those with PEX syndrome and control group ([@r18], [@r19]). Rufer *et al*. recorded no statistically significant differences, whereas Inoue *et al*. report on thinner cornea in patients with PEX syndrome with or without glaucoma as compared with control group, but found no statistically significant difference between the PEX syndrome and PEX glaucoma groups. They report on the association between reduced corneal endothelial cell count and decreased CCT value in patients with PEX glaucoma ([@r20], [@r21]). The onset of PEX syndrome is known to be accompanied by corneal lesions that manifest as alterations of the corneal epithelial, stromal and endothelial cells, as well as of Descemet's membrane of the cornea. These alterations include changes in the cell number and morphology that occur due to metabolic changes, production and accumulation of PEX material, and changes in aqueous humor, resulting in cell disintegration, migration, uncontrolled proliferation and eventually apoptosis, with aggravation of these alterations in the presence of elevated intraocular pressure ([@r20]-[@r23]). Corneal lesions in PEX syndrome can cause corneal decompensation and are a major factor in the assessment of postoperative results.

In the present study, patients diagnosed with PEX syndrome/cataract and those with PEX glaucoma/cataract had a statistically significantly thicker lens than patients diagnosed with POAG/cataract (4.7±0.444 mm and 4.7±0.417 mm *vs*. 4.4±0.417 mm, respectively; Scheffe test, p=0.041 and p=0.018, respectively). Lens thickness did not differ between patients with PEX syndrome/cataract and those with PEX glaucoma/cataract (Scheffe test, p=0.995). The lens grows with age and the mentioned differences can in part be explained by advanced age of patients in the groups with PEX syndrome with and without glaucoma; however, lens surface in PEX syndrome is known to manifest structural central and peripheral alterations. Formation of a precapsular layer made of profibrillar material, followed by formation of a layer consisting of organized PEX material and pigment has been identified by electron microscopy and histochemistry. Localized accumulation of PEX material and degenerative changes resulting in disintegration at capsular holder occur in the area of zonule insertion. Tension and contact between the lens capsule and zonule decrease with weakness of the zonular apparatus, rendering the lens thicker and ever more mobile. Using US biomicroscopy, Unsal *et al*. detected thicker lens and degenerative changes at the zonule capsular holder in the eye with PEX syndrome, unlike the other eye without PEX syndrome ([@r23]). Some literature reports speculate that weakness of the zonular apparatus and increased lens thickness may cause lens antepositioning and decreased depth of the anterior chamber. These changes pose a risk of chamber angle closure and onset of glaucoma in PEX syndrome, as well as of intra- and postoperative complications in cataract surgery ([@r10]-[@r13]). Increased lens thickness leads to closer iridolental contact and potential formation of adhesions, which will also result in increased resistance to aqueous humor drainage and development of glaucoma. These alterations, as well as epithelial and stromal changes of the ciliary muscle and iris are additional factors contributing to the inability of adequate mydriasis and reduced pupillometry in cataract surgery, thus increasing the risk of intra- and postoperative complications. Employing OLCR, Bosnar *et al*. found statistically significantly lower ACD and PD values and a statistically significantly thicker lens in the sample of eyes with PEX syndrome and cataract as compared with the eyes with cataract ([@r15]). Naumann confirmed lower PD values in the eyes with PEX syndrome ([@r24]-[@r26]). In our study, comparative analysis of study groups yielded no statistically significant differences in the measured PD and ACD values, although the mean ACD value was below 2.5 mm in the groups with PEX syndrome/cataract and PEX glaucoma/cataract (2.3±0.397 mm and 2.4±0.551 mm, respectively), which could in part be explained by greater lens thickness and inadequate response to medicamentous mydriasis due to the iris and zonular apparatus alterations described above.

Küchle *et al*. report that ACD \<2.5 mm correlates with a fourfold greater risk of intraoperative complications ([@r12]). Pupillometry was lowest in the PEX glaucoma/cataract group (4.6±0.92 mm) as compared with POAG/cataract group (5.1±1.32 mm) and PEX syndrome/cataract group (5.2±1.194 mm), however, without statistical significance (F=2.732; ss=2/93; p=0.07). Smaller pupillary diameter points to possible association with structural changes of iris tissue, presence of iridolental adhesions, glaucoma, and greater likelihood of intraoperative complications. On analysis of biometric status according to age, a statistically significant correlation was recorded for LT (r=0.472; p=0.027) and WTW (r=0.512; p=0.015) in the PEX glaucoma/cataract group. Older patients had thicker lens and smaller corneal diameter. WTW is an indirect indicator of iris diameter, lens capsule diameter, ciliary sulcus and anterior chamber depth, and in this case an important factor in the assessment of intraocular lens choice and positioning.

Conclusion
==========

Using OLCR, we found differences in the values of biometric factors among the study groups, and a statistically significantly thinner cornea and thicker lens in the group of glaucomatous patients with PEX syndrome. Our results confirmed OLCR as a biometric method in preoperative diagnosis to help in detecting glaucomatous patients with PEX syndrome. The purpose of the study was to instigate scientific ideas in search for novel methods to diagnose specificities of ocular biometric factors in glaucomatous patients with PEX syndrome.
